Cargando…
Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
BACKGROUND: Postpartum hemorrhage (PPH) remains a major killer of women worldwide. Standard uterotonic treatments used to control postpartum bleeding do not always work and are not always available. Misoprostol's potential as a treatment option for PPH is increasingly known, but its use remains...
Autores principales: | Zuberi, Nadeem F, Durocher, Jill, Sikander, Rozina, Baber, Neelofur, Blum, Jennifer, Walraven, Gijs |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2529259/ https://www.ncbi.nlm.nih.gov/pubmed/18718007 http://dx.doi.org/10.1186/1471-2393-8-40 |
Ejemplares similares
-
Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial
por: Mobeen, N, et al.
Publicado: (2011) -
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012) -
Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013) -
High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010) -
Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
por: Hofmeyr, G Justus, et al.
Publicado: (2004)